Esperion Therapeutics (ESPR) Cash from Investing Activities (QoQ) (2012 - 2024)
Esperion Therapeutics (ESPR) Cash from Investing Activities (QoQ) (2012 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Esperion Therapeutics | 799.30 Mn | 643.14 Mn | 45.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -116.88% |
| Jun 30, 2024 | -5.48% |
| Jun 30, 2023 | -30.00% |
| Mar 31, 2023 | 311.97% |
| Dec 31, 2022 | -135.74% |
| Sep 30, 2022 | 560.00% |
| Jun 30, 2022 | 127.62% |
| Mar 31, 2022 | 64.14% |
| Dec 31, 2020 | -643.33% |
| Sep 30, 2020 | -54.34% |
| Jun 30, 2020 | -80.78% |
| Mar 31, 2020 | 1,027.09% |
| Dec 31, 2019 | 46.02% |
| Sep 30, 2019 | -119.89% |
| Jun 30, 2019 | -41.54% |
| Mar 31, 2019 | 18.48% |
| Dec 31, 2018 | -3.65% |
| Sep 30, 2018 | 26.79% |
| Jun 30, 2018 | 4.25% |
| Mar 31, 2018 | -37.43% |